7 August 2015 -  The National Health Act 1953 has recently been amended to implement measures announced as part of the PBS Access and Sustainability package. This includes removing the originator brand from price disclosure calculations.

More information on the amendments to the Act and explanatory material can be found on the Parliament of Australia website.

A table of PBS drugs on the F2 formulary and brands which it is proposed may be determined as originator brands (under subsection 99ADB(6B)of the Act) is included below. The table has been updated to reflect 1 August 2015 changes to include propranolol and remove a brand of desferrioxamine. Several additional Diabex brands omitted in error from the previous version have been included. These changes are not in response to comments received from stakeholders.

For more details, go to: http://www.pbs.gov.au/info/news/2015/08/originator-list-for-pbs-medicines-f2-formulary-aug-2015-news/